Evidence that treatments targeting both the tumor epithelia and the surrounding CAFs can extend the efficacy of conventional chemotherapies is provided by the retinoic acid receptor β and androgen receptor antagonists identified for concurrent therapy with cisplatin [36]. The gene discussed is AR; the disease is neoplasm.